Inappropriate Antimicrobial Dosing in Regard to Renal Function in a Tertiary Hospital in Greece-A Single-Center Point

Petros Ioannou1,2, Andria Papazachariou2, Stamatis Karakonstantis1,2

  • 1School of Medicine, University of Crete, 71003 Heraklion, Greece.

Insights

Inappropriate antimicrobial dosing for kidney function is common in hospitals, affecting 15.7% of patients. Older patients and those with impaired renal function are most at risk for dosing errors, highlighting a need for improved antimicrobial stewardship.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Appropriate antimicrobial dosing adjusted for kidney function is crucial for treatment efficacy and preventing resistance.
  • Despite guidelines and electronic systems, antimicrobial dosing errors in patients with impaired renal function are frequent.

Purpose of the Study:

  • To evaluate the appropriateness of antimicrobial dosing in relation to renal function in hospitalized patients.
  • To identify specific drugs and patient groups with higher rates of dosing errors.

Main Methods:

  • A point-prevalence study was conducted in a tertiary-care hospital in Greece.
  • Patient data, including renal parameters and antimicrobial prescriptions, were extracted from electronic medical records.
  • Glomerular filtration rate (GFR) was estimated using the MDRD formula.

Main Results:

  • 15.7% of 235 hospitalized patients received inappropriate antimicrobial doses based on renal function.
  • Ceftazidime, cefuroxime, colistin, and acyclovir had high error rates; piperacillin/tazobactam had a lower rate but was frequently prescribed.
  • Patients with dosing errors were older, had poorer renal function, and received more antimicrobials.

Conclusions:

  • Inappropriate antimicrobial dosing is a significant issue in hospitalized patients, especially the elderly and those with renal impairment.
  • Targeted antimicrobial stewardship strategies are needed to improve renal dose adjustments for specific drugs and patient populations.
  • Enhancing prescribing safety and optimizing therapeutic outcomes requires focused interventions on common dosing errors.

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
371
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
423
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
386
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842